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ABSTRACT 
 
BAKED AND BUZZED: INVESTIGATING THE INFLUENCE OF CO-USE OF CANNABIS 
AND ALCOHOL ON WHITE MATTER INTEGRITY IN EMERGING ADULTS 
 
by 
Natasha E. Wright 
The University of Wisconsin-Milwaukee, 2018 
Under the Supervision of Professor Krista M. Lisdahl 
  
 Objective: Growing evidence suggests alcohol and cannabis use independently alter 
neural structure and functioning, particularly during sensitive developmental time periods such 
as adolescence and emerging adulthood. However, there has been minimal investigation into the 
effects co-occurring use of these two substances, despite preliminary evidence of unique acute 
and psychopharmacological changes due to using alcohol and cannabis together.  
 Method: Data drawn from the IDEAA Consortium was utilized to assess white matter 
integrity as measured by FreeSurfer’s TRACULA in emerging adults (n=192; 16-27 years old). 
Timeline Follow-Back was used to calculate past month cannabis use, alcohol use, co-use days, 
binge alcohol episode, and co-use-binge days. The Stroop task was administered and normed 
scores were used. Multiple regressions investigated white matter integrity by past month 
cannabis, alcohol, and co-use days, controlling for appropriate covariates (e.g., site, gender, 
education, length of abstinence). Analyses were run twice, once with alcohol as measured in 
standard units and once with binge episodes. Follow-up brain-behavior analyses assessed 
whether substance use or tracts that differed significantly by substance use then related to Stroop 
performance. Correction for multiple comparisons was conducted using Benjamini and 
Hochberg’s (1995) False Discovery Rate correction method. 
	   iii	  
 Results: Corrected for multiple comparisons, cannabis use was significantly related to 
increased mean diffusivity in 12 fronto-limbic and fronto-parietal tracts. Cannabis use also 
associated with poorer performance on Stroop word reading. Within the MJ+ALC group, 
increased mean diffusivity associated with better Stroop interference performance. 
 Discussion: The present study found cannabis use was associated with decreased white 
matter integrity, as measured by mean diffusivity, across fronto-parietal and fronto-limbic tracts. 
These results suggest a robust relationship between cannabis use and white matter integrity in 
this neurodevelopmentally sensitive time period. Despite our hypotheses, co-use, alcohol use, 
and binge drinking did not significantly predict any measures. Future research should further 
investigate the potential independent and interactive affects of these substances on preclinical 
and clinical levels. Efforts should be made to inform the public of the likely negative impact of 
cannabis on white matter quality. 
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Introduction 
Adolescents and emerging adults undergo ongoing neurodevelopment, including 
structural and functional neuronal changes (Giedd et al., 1996; Gogtay et al., 2004; Shaw et al., 
2008), placing them at increased vulnerability to neurotoxins during this period (for review, see 
Bava & Tapert, 2010). Across the United States, almost one in fifteen 12th graders smoke 
cannabis daily, while one in four 12th graders have engaged in binge drinking (drinking 5 or 
more standard drinks on one drinking occasion) in the past two weeks (Miech, Johnston, 
O'Malley, Bachman, & Schulenberg, Patrick, 2017). Further, cannabis use is positively 
correlated with alcohol use (Johnston, O'Malley, Bachman, & Schulenberg, 2013) and 23% of 
high school seniors report simultaneously using both cannabis and alcohol in the past year, while 
15.3% of young adults (age 18-29) report using both substances together in the past year, 
(Subbaraman & Kerr, 2015; Terry-McElrath, O'Malley, & Johnston, 2013). Therefore, there is a 
great public health need to better understand the neurological consequences of such co-occurring 
substance use. This is especially true when considering that both alcohol and cannabis use and 
abuse have been found to have a wide range of neurocognitive and neuronal consequences in 
adolescents (for review, see Lisdahl, Gilbart, Wright, & Shollenbarger, 2013). 
The Developing Brain. Vast neurocognitive changes occur across the lifespan, 
particularly in adolescence and emerging adulthood (Gogtay et al., 2004). Improved executive 
functioning performance is associated with areas that undergo some of the most substantial 
development, including the prefrontal cortex (PFC), as well as through pruning of gray matter 
and cortical thinning (Giedd et al., 2015; Shaw et al., 2008) and white matter development 
(Gogtay et al., 2004). White matter development tends to follow an inverse ‘U’ shaped 
trajectory, with white matter integrity peaking in adolescence and young adulthood (Imperati et 
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al., 2011). In general, white matter tends to develop anterior to posterior and centrally to 
peripherally, though fronto-temporal tracts develop later in the maturation process (for review, 
see Yap et al., 2013). Understanding this neuroplasticity, particularly in regards to white matter, 
is key to facilitating healthy brain development in this time period (Spear, 2013). The sum of 
these neurodevelopmental and limbic system changes may make adolescents particularly 
vulnerable to engaging in risky behaviors as well as the neurotoxic consequences of substance 
use (for review, see Bava, Jacobus, Thayer, & Tapert, 2013; Bava & Tapert, 2010).  
Endocannabinoid System, Cannabis & Alcohol. The main psychoactive component of 
cannabis, delta-9-tetrahydrocannabinol (THC), directly binds to cannabinoid receptor 1 (CB1) in 
cortical, limbic, and striatal regions (Sim-Selley, 2003). It is notable that the endogenous 
cannabinoid (eCB) system plays a role in neurodevelopment. The eCB system contains two 
endocannabinoids, arachidonoyl-ethanolamine (anandamide; AEA) and 2-arachidonoyl-glycerol 
(2-AG), which can activate CB1 (for review, see Breivogel & Sim-Selley, 2009). Cannabinoid 
receptors are located on glutamergic and GABAergic neurons, among others (Alger, 2012). 
Endocannabinoids act as neuromodulators; after being activated postsynaptically, they bind to 
CB1 receptors in the presynaptic terminal, which in turn prevent neurotransmitter release (see 
Hillard, 2015). The eCB system also undergoes neuromaturation in adolescence and emerging 
adulthood, making it more vulnerable to exogenous cannabinoids and their deleterious effects on 
the eCB system, morphological changes, and overall functioning (for review, see Schneider, 
2008).  
Chronic cannabis use in young adults has been found to downregulate CB1 receptors in 
cortical and limbic regions, but this appears to be reversible with a month of abstinence in 
humans (Hirvonen et al., 2012). Alcohol also moderates CB1 receptor activity through 
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interacting with neurotransmitters (e.g., glutamate, GABA), with the CB1 receptors in turn 
modulating dopamine and GABA receptors, particularly in reward and limbic regions (Pava & 
Woodward, 2012). Acutely, alcohol consumption in rats has been found to result in a greater 
release of endocannabinoids while, at times, also inhibiting eCB signaling (Rubio, McHugh, 
Fernandez-Ruiz, Bradshaw, & Walker, 2007). More chronic alcohol use, though, has been linked 
to reduction of CB1 levels in an irreversible manner in humans (Hirvonen et al., 2013).  
As cannabis and alcohol both act on the same reward pathways, modulate similar 
neurotransmitter and ligand levels (e.g., GABA, dopamine, AEA, 2-AG; see Basavarajappa & 
Hungund, 2002; Cruz, Bajo, Schweitzer, & Roberto, 2008), and both downregulate eCB receptor 
activity (e.g., CB1), it may logically follow that there is potential for an additive or even 
synergistic effect when the two substances are used together. Indeed, the underlying mechanisms 
are similar enough that priming with one of these substances prior to use of the other substance, 
and vice-versa, has been shown to develop some level of cross-tolerance to either substance (for 
review, see Pava & Woodward, 2012). However, differences in these mechanisms also exist, 
alcohol stimulates GABA, while cannabinoids inhibit GABA transmission (Cruz et al., 2008). 
Pharmacologically, when looking at factors such as blood alcohol content (BAC), co-use of these 
substances may interact in such a way that they actually reduce BAC, as THC may slow alcohol 
absorption (Lukas et al., 1992). However, this may not always be the case; for example, Chesher 
and colleagues (1976) found BAC was increased when alcohol and THC were simultaneously 
administered in capsules. Ballard and de Wit (Ballard & de Wit, 2011), in contrast, found no 
pharmacokinetic difference when low doses of ethanol and capsule THC were administered in 
humans. When cannabis is used in combination with alcohol, plasma and blood THC levels 
increase (Hartman et al., 2015; Lukas & Orozco, 2001) and heart rate, a correlate of THC 
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absorption, remains higher (Ronen et al., 2010). Cannabinoids may also potentiate the 
deleterious effects of alcohol, as found in rodent youths through priming for apoptosis (Hansen 
et al., 2008). Therefore, chronic use of alcohol or cannabis in adolescent and emerging adult 
years may disrupt the role the eCB system plays in healthy neurodevelopment. However, there is 
currently too little evidence to be able to fully understand alcohol and cannabis co-use on 
neuropharmacology and their underlying mechanisms.  
Co-Use of Cannabis and Alcohol. On a behavioral level, co-occurring use of alcohol and 
cannabis has generally been found to be linked to poorer outcomes, such as poorer treatment 
outcomes, higher rates of depression, and higher positive expectancies of use and, in turn, 
increased use of any substances (Aharonovich et al., 2005; Lopez-Quintero et al., 2011). One 
possible reason for these poorer outcomes is that combined use has been related to greater 
neurocognitive deficits. Studies examining the acute administration effects of cannabis and 
alcohol often suggest an additive effect on cognition, attention, memory, and motor functioning 
(Belgrave et al., 1979; Chait & Perry, 1994; Chesher, Franks, Jackson, Starmer, & Teo, 1977; 
Marks & MacAvoy, 1989), though not always (Ballard & de Wit, 2011; Bramness, Khiabani, & 
Morland, 2010; Ramaekers et al., 2011). Notably, almost all acute administration studies use 
very low doses of THC (1.3-3.0%; with the exception of Ramaekers et al., 2011), who used 11% 
THC), which may limit generalizability to contemporary doses of cannabis as found in the 
general population (averaging 12% THC; ElSohly et al., 2016).  
Diffusion Tensor Imaging & White Matter Integrity. A common marker of brain health 
and function, as well as a key neurodevelopmental measure in emerging adulthood (Giedd, 2004; 
Gogtay et al., 2004), is the diffusion of water across white matter tracts in diffusion tensor 
imaging (DTI) (Basser, James, & LeBihan, 1994; Le Bihan, 2003). Such diffusion of water 
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indicates differences in neuromicrostructural integrity and architecture, and may be indicative of 
neural damage before other measures of brain health (e.g., volumetric analyses in gray matter; 
Soares, Marques, Alves, & Sousa, 2013). Healthy oligodendrocyte, and therefore white matter, 
development requires CB1 receptors protect progenitors from apoptosis (Molina-Holgado et al., 
2002); thus, downregulation of CB1 receptors due to regular cannabis use (Hirvonen et al., 2012) 
may disrupt typical white matter development. Similarly, binge-like ethanol use in adolescent 
rats has been found to decrease protein levels (myelin basic protein and myelin oligodendrocyte 
glycoprotein) related to myelin development (Pascual, Pla, Minarro, & Guerri, 2014). Loss of 
axonal proteins, myelin proteins, and enzymes in mice have also been found following chronic 
intermittent ethanol exposure (Samantaray et al., 2015). Therefore, cannabis and alcohol may 
disrupt healthy white matter development in adolescents and emerging adults. 
 Effects of Cannabis, Alcohol, and Co-Use on White Matter. In young adult cannabis 
users, with few exceptions (Cousijn et al., 2012; Delisi et al., 2006), the majority of studies have 
reported poorer white matter integrity in cannabis users in comparison to healthy controls. 
Increased mean diffusivity (MD; (Arnone et al., 2008; Gruber, Dahlgren, Sagar, Gonenc, & 
Lukas, 2014; Shollenbarger, Price, Wieser, & Lisdahl, 2015) and decreased fractional anisotropy 
(FA; (Arnone et al., 2008; Ashtari et al., 2009; Bava et al., 2009; Clark, Chung, Thatcher, Pajtek, 
& Long, 2012; Gruber et al., 2014; Jacobus, Squeglia, Bava, & Tapert, 2013; Shollenbarger, 
Price, Wieser, & Lisdahl, 2015) have been found in prefrontal, parietal, cerebellar, corpus 
callosum, and temporal regions in regular cannabis emerging adult users. 
In studies investigating the effects of alcohol use on WM integrity, a recent meta-analysis 
found substance-using adolescents to largely have deficits in white matter microstructure in 
neocortical, thalamic, and projection pathways (Baker et al., 2013). With one exception 
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(Cardenas et al., 2013), adolescent alcohol users have been found to have reduced white matter 
integrity relative to healthy controls in areas such as the corpus callosum, inferior longitudinal 
fasciculus (ILF), and superior longitudinal fasciculus (SLF) (Bava et al., 2013; Clark et al., 2012; 
Hill, Terwilliger, & McDermott, 2013; Jacobus et al., 2009; Lisdahl, Thayer, et al., 2013; 
Luciana, Collins, Muetzel, & Lim, 2013; McQueeny et al., 2009). Adolescent binge drinkers 
have also been found to have reduced white matter quality (McQueeny et al., 2009) and smaller 
cerebellar volumes (Lisdahl, Thayer, Squeglia, McQueeny, & Tapert, 2013). 
 Oftentimes cannabis users co-use alcohol, and vice versa. In studies investigating 
cannabis and alcohol co-use on WM, conflicting results are found. For example, Jacobus and 
colleagues (2013) found co-use to be worse than alcohol use alone as measured by poorer WM 
integrity in young adults who were not using substances in their late adolescence but transitioned 
into use in early adulthood (ages 19-22). Notably, this study was absent a healthy control group 
or a cannabis-only group, and had only 8 individuals per group. Another study (Bava et al., 
2009) investigated WM integrity in 36 cannabis and alcohol users and in 36 healthy controls, 
finding 10 clusters with decreased FA and 3 with increased FA in the co-use group. Though they 
attempted to investigate the potential influence of cannabis, they did not have a cannabis- or 
alcohol-only group, making it difficult to tease apart the unique or even combined contributions 
of each substance. In another study, Jacobus and colleagues (2009) concluded that binge-and-
cannabis users had poorer white matter integrity relative to binge alcohol users alone in a 
relatively small sample of 16-19 year olds (n=14 per group). However, the binge-and-cannabis 
group drank significantly more in their lifetime, though not in the past three months. Further, 
while the binge-and-cannabis group demonstrated better WM integrity than binge alone in some 
regions, increased alcohol use was also, at times, related to increased FA values. Together, this 
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shows overall aberrant results from what would typically be expected. De Bellis and colleagues 
(De Bellis et al., 2008) assessed WM deficits in 32 adolescents (12-18 years old) with an alcohol 
use disorder (AUD), 22 of whom also had a cannabis use disorder (CUD), in comparison to 28 
healthy controls. The AUD subjects who also had CUD had greater differences in WM integrity; 
however, this was characterized by increased FA and decreased MD in the corpus callosum, 
which is in the opposite direction as expected and which the authors explained as being evidence 
of aberrant maturation of myelination perhaps as a sign of premature aging due to neurotoxicity. 
Importantly, the AUD subjects were not screened for psychiatric comorbidities, and even some 
of the healthy controls previously met criteria for other disorders, but did not currently meet 
diagnostic criteria. In an 18-month longitudinal investigation of 16 to 20 year olds who used any 
amount or variety of substances, Bava and colleagues (2013) found differences in WM integrity 
between substance users compared to non-users. In follow-up regression analyses, the onset of 
alcohol use, but not cannabis use, predicted reductions in white matter integrity in seven clusters: 
the left and right SLF, right posterior thalamic radiations, right prefrontal thalamic fibers, right 
superior temporal gyrus, right ILF, and the left posterior corona radiata. However, the extensive 
use of other illicit-substances confounds the potential to differentiate the relationship between 
each particular substance and WM integrity. More recently, Squeglia and colleagues (Squeglia et 
al., 2015) found general morphological differences in cannabis-and-alcohol users above and 
beyond that found in heavy alcohol-use-alone in comparison to healthy controls a longitudinal 
study, with greater attenuation in the medial frontal cortex and insula; however, they also found 
larger volumes in the corpus callosum when comparing cannabis-and-alcohol users to heavy-
alcohol-users alone, leading to equivocal results. Importantly, the controls appropriately had very 
limited substance (alcohol or cannabis) use; however, there were no singular (alcohol OR 
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cannabis alone) groups, but one co-use (alcohol AND cannabis) group, limiting the ability to 
differentiate the influence of each substance. In addition, some participants in the co-use group 
had extensive histories of other illicit substance use beyond cannabis use.  
In sum, these investigations have begun to tease apart the microstructural implications of 
adolescent and emerging adult substance co-use, but have been limited by a number of factors. 
Studies thus far have used group analyses rather than assessing dose-dependent relationships or 
the potential interactive effects of alcohol and cannabis in co-occurring use episodes. Only one 
co-use study (Winward, Hanson, et al., 2014) used an adequate sample, including a cannabis-
only group and well-characterized and matched each substance group with the co-use group; 
however, this study investigated neurocognition alone, rather than neuroanatomy, and did not 
look at patterns of substance use. Studies often only looked at total amount of use or group 
status, rather than patterns of use (e.g., estimated number of lifetime uses per substance rather 
than the present study’s number of co-occurring use events). Indeed, no known study to date has 
investigated patterns of use, which may be an important determinant of effects due to potential 
pharmacological differences in co-occurring use (Chesher et al., 1976; Lukas et al., 1992; Lukas 
& Orozco, 2001). Therefore, there is a need to have a well-powered analysis of the independent 
and interactive effects of cannabis and alcohol, while also investigating the patterns of co-use, on 
WM integrity in substance users and controls whose drug use patterns are clearly defined. 
Substance Use and Executive Functioning. Executive functioning deficits are a suspected 
consequence of substance use in emerging adults (for review, see Lisdahl, Gilbart, et al., 2013). 
In regards to cannabis, this is likely due to the high level of CB1 receptors in the prefrontal 
cortex (Terry et al., 2009), as frontal regions have been shown to be activated during executive 
functioning tasks such as the Stroop task (Egner & Hirsch, 2005). Across adolescence, 
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neurodevelopmental changes in healthy adolescents have been linked to performance on a 
measure of executive functioning, the Stroop Task (Vijayakumar et al., 2014). Early onset of 
marijuana use has been found to be predictive of poorer Stroop performance relative to late onset 
use to healthy controls in a number of studies (Gruber, Sagar, Dahlgren, Racine, & Lukas, 2012; 
Sagar et al., 2015). Assessing brain-behavior relationships, several studies have also 
demonstrated altered functional processing of the Stroop task in MJ users, finding generally 
more disparate and diffuse activation in the DLPFC, PFC, and ACC is required for similar 
performance attainment (Banich et al., 2007; Gruber & Yurgelun-Todd, 2005; Sagar et al., 
2015). In alcohol, disrupted prefrontal macro- and microstructure is a frequently reported finding 
(see Lisdahl, Gilbart, et al., 2013). Dysexecutive performance as measured through the Stroop 
task, then, makes logical sense. However, few studies in adolescents and young adults have 
found direct links between alcohol consumption and Stroop performance, with other studies 
containing null findings despite self-reported daily executive functioning deficits (Gil-Hernandez 
& Garcia-Moreno, 2016). Interestingly, one study administered the Stroop task in the fMRI 
scanner, finding no performance difference but less activation in the cuneus and precuneus in 
alcohol users (Thayer et al., 2015). Greater consideration of the executive functioning deficits 
associated with substance use are warranted. 
Summary and Aims. Much remains to be discovered regarding co-occurring alcohol and 
cannabis use, given the nascent state of the literature. Indeed, even the studies that do exist often 
exclude for moderate use—a group that may have distinct qualitative characteristics or 
neuroanatomical or neurocognitive effects. However, preliminary studies suggest a potential 
additive affect of combined cannabis and alcohol use. CB1 receptor activity is downregulated by 
chronic cannabis (Hirvonen et al., 2012) and alcohol use (Hirvonen et al., 2013). Disrupted CB1 
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receptor activity may, in turn, affect white matter development, as healthy white matter is 
influenced by CB1 activity, and binge-like alcohol use (e.g., (Molina-Holgado et al., 2002; 
Pascual et al., 2014; Samantaray et al., 2015). Combined, alcohol and cannabis may have a 
cross-tolerance (see Pava & Woodward, 2012), and THC levels may increase while conflicting 
studies have shown reduced BAC (Lukas et al., 1992) and increased BAC (Chesher et al., 1976). 
A number of studies (Belgrave et al., 1979; Chait & Perry, 1994; Chesher et al., 1977; Marks & 
MacAvoy, 1989), though not all (Ballard & de Wit, 2011; Bramness et al., 2010; Ramaekers et 
al., 2011), have also found acute additive affects on cognition when the two substances are used 
together. Literature on chronic use is more limited. Given the potential for underlying 
mechanistic changes that may relate to anatomical and functional changes, more research into the 
effects of co-occurring cannabis and alcohol use is needed. 
The present study examined structural connectivity in cannabis and alcohol using male 
and female adolescents and emerging adults utilizing DTI tractography to assess white matter 
integrity with a wide range of substance use patterns. The potential independent effects of 
alcohol, cannabis, and cannabis+alcohol co-occurring use on white matter integrity were 
assessed. In addition, in order to assess whether structural differences in white matter integrity 
between groups relate to functional performance, the relationship between performance on a 
neuropsychological task of executive functioning and white matter integrity was examined. 
Secondarily, to examine whether larger amounts of alcohol consumed in one episode may have 
differential effects, each analysis was repeated with number of binge drinking and MJ+binge 
episodes, rather than total alcohol consumed.  It was hypothesized that greater recent cannabis 
use will predict increased MD and decreased FA in fronto-parietal tracts and fronto-limbic tracts 
(specifically, within the uncinate fasciculus; the cingulum angular bundle; the cingulum 
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cingulate gyrus; anterior thalamic radiation, or ATR; the corpus callosum forceps major and 
forceps minor; the SLF, both parietal and temporal portions; and the ILF; Ashtari et al., 2009; 
Clark et al., 2012; Gruber et al., 2014; Jacobus, Squeglia, Bava, et al., 2013; Shollenbarger et al., 
2015). Similarly, it was hypothesized that greater recent drinking will predict increased MD and 
decreased FA in these same tracts (Bava et al., 2013; Jacobus et al., 2009). Another primary aim 
was to assess the combined effects of alcohol and cannabis co-occurring use on white matter 
integrity. Given the attenuation of THC metabolism (Hartman et al., 2015; Lukas & Orozco, 
2001; Ronen et al., 2010) and the proposed potentiation of alcohol on THC neurotoxicity 
(Hansen et al., 2008), it was predicted that co-occurring MJ and alcohol use would have an 
additive effect, such that there would be greater decrements in white matter integrity in fronto-
parietal and fronto-limbic tracts than alcohol or cannabis use alone. The secondary aim of the 
study was to assess brain-behavior relationships, predicting that, in tracts that are significantly 
related to alcohol use, cannabis use, or cannabis+alcohol co-use, poorer WM integrity will be 
associated with poorer cognitive performance (Anderson, Rabi, Lukas, & Teicher, 2010; 
Chanraud et al., 2009; Gruber et al., 2014; Gruber, Silveri, Dahlgren, & Yurgelun-Todd, 2011). 
Methods 
Overview. The present study analyzed data collected by the Imaging Data in Emerging 
Adults Addiction (IDEAA) Consortium (PIs: Krista Lisdahl, Ph.D., UWM site, Staci Gruber, 
Ph.D., McLean site, Francesca Filbey, Ph.D., UTD site, and Susan Tapert, Ph.D., UCSD site). 
One-hundred and ninety-two participants were included in one combined dataset drawn from the 
IDEAA Consortium PI’s individual projects. Data from UCSD, UWM, and McLean were used 
in the present study. 
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Participants. Data from a total of 192 individuals, aged 16-27, were used for the present 
study and although the study focused on dose-dependent effects, participants were classified into 
distinct groups for selection of potential covariates (cannabis only, or MJ; alcohol only, or ALC; 
cannabis and alcohol co-use, or MJ+ALC; and healthy controls, or HC) and secondary brain-
behavior analyses. The Institutional Review Boards at the University of Wisconsin-Milwaukee, 
Medical College of Wisconsin, McLean Hospital, and University of California San Diego have 
approved all aspects of this study, and all participants provided written informed consent. Groups 
were assessed for differences in sociodemographic information, such as gender, age, ethnicity, 
and education level. Any significant differences between groups were used as covariates in the 
subsequent analyses. Gender was the only variable that differed by substance group and, 
therefore, was included as a covariate; in the binge analyses, groups differed on education level 
and length of abstinence so these variables were included in those analyses as covariates.  
 All participants across sites were recruited for participation in a substance use study. For 
the current analysis, the following group definitions were used. MJ Criteria: MJ participants used 
at least half a gram of cannabis a week, on average, over the past month. They used less than 20 
standards drinks of alcohol in the past month. ALC Criteria: ALC participants drank at least 20 
standard drinks on average over the past month and used less than half a gram of cannabis a 
week. MJ+ALC Criteria: MJ+ALC participants exhibited patterns of regular substance use 
averaged over the past month (consuming =/> 20 standard drinks a month, use cannabis =/>0.5 
gram a week). HC Criteria: Controls used less than 20 standards drinks of alcohol in the past 
month and less half a gram of cannabis per week on average over the last month.  
 Exclusion Criteria for All Participants: Current use of psychotropic medication, lifetime 
history of serious neurologic injuries or disorders, major medical illness, diagnosis of an 
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independent Axis I psychiatric disorder in past year (except for Substance Abuse or Dependence 
in any of the substance using groups), pregnancy, or MRI contraindications (e.g., metal 
anywhere in or on the body, greater than 250 lbs, claustrophobia). McLean allowed for left-
handedness, and, therefore, three left-handed participants were included; all other sites excluded 
for left-handedness. Alcohol and breathalyzer screens verified .000 breath alcohol concentration 
at all study sessions. For McLean site only, recent binge drinking (defined as 4 or more drinks 
for a female, 5 or more drinks for a male, within a 2 hour period) was an exclusion criteria; 
therefore, McLean’s participants were excluded from any binge-specific analyses.  
Procedure. Eligible participants completed each respective parent study protocol and 
were asked to come to the MRI scanning center at each of the respective institutions. They were 
asked to remain abstinent from all substance use other than cigarettes for a minimum of 12 hours 
prior to session start. Participants were given breathalyzer and toxicology tests. UCSD and 
UWM also collected pregnancy tests for females; McLean Hospital relied on subject self-report 
of pregnancy. Positive results on either the pregnancy (when used) or breathalyzer tests regarded 
participants as ineligible, and they were subsequently given small compensation for their time. If 
negative, participants were given psychological questionnaires to assess mood and psychological 
variables. Participants then completed the neuroimaging and neurocognitive testing protocols. 
All participants were compensated for their time. 
Recent Drug Use. At all sites, drug use history was collected using the Timeline Follow-
Back (TLFB; Sobell & Sobell, 1992). Using a calendar to cue special dates and holidays, 
participants were asked to recount when they used alcohol (standard drinks), cannabis (grams), 
co-occurring alcohol and cannabis (days of co-use). Number of binge drinking episodes (≥4 
drinks for females, ≥5 for males in one drinking occasion, not limited by hours) was also 
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calculated for UWM and UCSD site participants. Data for past month of use was averaged to the 
past month (30 days), as each site collected varying lengths of time. When available, length of 
abstinence was calculated (McLean site did not calculate this due to their short, 12 hour, period 
of time of required abstinence for participants).  
Measures. A different set of neuropsychological measures were administered at each site; 
however, each used a version of the Stroop task (e.g., Comalli Stroop; Comalli, Wapner, & 
Werner, 1962), which is used in the present analyses. UWM and UCSD both administered the D-
KEFS Color-Word Interference Task (Delis, Kaplan, & Kramer, 2001). It consists of four 
subtests: a word reading list, a color naming list, a color-word list, and a color-word+word 
reading list. Time to complete each condition was measured. Only the first three subtests are 
included in the proposed study to better match the other sites. McLean Hospital utilized the 
Comalli Stroop (Comalli et al., 1962), which allows a set amount of time to read and/or name as 
many words/colors as possible; total number of words/colors read was measured. Total reading 
score, total color naming score, and total color-word interference score were calculated. Each 
subject’s performance was converted to the correct version’s normed scores. It was then 
converted to a z-score, allowing for comparison across sites and versions.  
MRI Data Acquisition. Each site used a standardized acquisition protocol on its 
respective 3T scanner (GE, Siemens, or Phillips). See Table 1 for specific structural acquisition 
parameters by site.  
Diffusion Tensor (DTI) Image Acquisition. Diffusion Tensor Imaging (DTI) was 
similarly obtained standardized protocols at each site (see Table 2). Raw DTI data was then 
uploaded to the IDEAA server pre-processed all DTI data by the UWM site in order to ensure 
consistency and all DTI datasets underwent the same exact preprocessing pipeline on the same 
15	  
computer system using a script capable of handling data from multiple scanner platforms. All 
structural data, including tracts of WM through FreeSurfer’s Tracks Constrained by Underlying 
Neuroantomy (TRACULA), was processed by UWM, again to ensure consistency across 
datasets.  
DTI Processing. FreeSurfer software was used to pre-process all T1-weighted 3D 
anatomical datasets, correcting for motion, non-parametric non-uniform intensity normalization, 
MNI transformation, removal of non-brain material, and skull-stripping. Whole-brain 
segmentation of white and gray matter was then completed. TRACULA (a software program 
within FreeSurfer) was then used to reconstruct white matter pathway from DTI images using a 
global probabilistic tractography program. This yields measures of white matter integrity, 
including fractional anisotropy (FA) and mean diffusivity (MD) (Yendiki et al., 2011). Each 
image underwent the following preprocessing steps: (1) Image Corrections (e.g., for B0 
inhomogeneities, eddy currents, and simple head motion), (2) Further head motion correction, (3) 
Intra-subject and Inter-subject registration (4) Mask creation (white matter is extracted from 
FreeSurfer’s segmentation and parcellation and combined into a mask), (5) Tensor fit, and (6) 
Estimation of pathways by combining the individual’s data with an atlas. Following 
preprocessing, a ball-and-stick model of diffusion was fitted to the images. Markov Chain Monte 
Carlo sampling was used to measure diffusion in each voxel, then establishing the likelihood of 
locations of tract for each subject. From these estimated pathways, statistics on diffusion 
measures (average weighted FA and MD) within each individual were extracted and exported 
into SPSS for regression analysis. Correction for multiple comparisons was conducted using 
Benjamini and Hochberg’s (1995) False Discovery Rate (FDR) correction method. 
Data Analysis. All analyses were conducted in SPSS.  
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Preliminary Analyses. Although the primary analyses used dose-dependent independent 
variables, differences in demographic data and psychological indices were examined with 
ANOVA and chi-square analyses between groups (gender, age, education, race, ethnicity, 
handedness). Variables that differentiated the groups were included in subsequent analyses as 
covariates, along with study site; gender was the only variable that differed by group and 
therefore was include in each analysis for all participants. When investigating analyses by group 
with only binge data, length of abstinence and education differed, and so were included in all 
binge analyses. 
Primary Analyses. A series of multiple regressions (FA and MD of specific hypothesized 
tracts) examined the study aims. For the first primary analysis (N=192), the independent 
variables included: past month drinking (standard drinks), past month cannabis (total grams), and 
co-occurring alcohol-cannabis smoking days. Covariates included study site and important 
demographics that may differ by group (i.e., gender). Next, the influence of binging was assessed 
by including past month binge episodes, past month cannabis, and number of co-occurring 
binge-cannabis days, and included covariates (i.e., study site, length of abstinence, and 
education) (N=134). All regression analyses were corrected for multiple comparisons by the 
FDR method (Benjamini & Hochberg, 1995).  
 Secondary Analyses. For secondary analyses, 167 of the 192 participants completed a 
version of the Stroop task. To assess brain-behavior relationship, multiple regressions were run, 
assessing whether differences in white matter integrity predict performance on a 
neuropsychological task of executive functioning, controlling for study site. As sites varied in 
versions of measures administered, each subject’s normed performance on a task was 
transformed into a z-score. This was then used in all statistical analyses. Analyses were 
17	  
completed by substance use group, to ensure that no significant differences would be obscured if 
relationships were in opposing directions. 
 In addition, the relationship between past month substance use and Stroop performance 
was examined. First, total past month alcohol (standard drinks; 1 ounce of liquor, 4 ounces of 
wine, 12 ounces of beer), cannabis (grams), and co-occurring alcohol-cannabis smoking days 
were investigated to see if they were associated with Stroop performance, when controlling for 
covariates. Next, past month binging episodes (number of binge drinking episodes; ≥4 drinks for 
females, ≥5 for males in one drinking occasion, not limited by hours), cannabis (grams), and co-
occurring binging-cannabis episodes (co-occurring alcohol and cannabis, days of co-use-binge; 
binging defined as ≥4 drinks for females, ≥5 for males in one drinking occasion, not limited by 
hours), along with appropriate covariates, were investigated to see if they were associated with 
Stroop performance. 
 
Results 
 Demographics. Participants were recruited from different regions of the United States (59 
from the West Coast; 75 from the Midwest; 58 from the East Coast). When including all three 
sites, groups significantly differed by gender (F(187)=3.49, p=.02); no other demographic 
variables were significantly associated with group status. When investigating analyses by group 
with only binge data (UWM and UCSD), length of abstinence (F(121)=2.82, p=.04) and 
education (F(130)=2.73, p=.05) differed, and so were included in all binge analyses. 
In addition, participants were divided between those who had (CO) and had not (NO) 
used alcohol and cannabis on the same day in the past month, though these groups were used in 
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no analyses and were assessed strictly for descriptive purposes. They did not differ in age, 
education, gender, ethnicity, race, or handedness. 
Substance Use Patterns. Participants exhibited a wide range of substance use in the past 
month (alcohol standard drinks: mean=19.68, SD=26.75, range=0-167.14; cannabis use in 
grams: mean=8.33, SD=18.14, range=0-139.91; number of binge episodes: mean=1.36, 
SD=2.85, range=0-15; see Table 5). Substance use differed significantly by group in past month 
cannabis use [F(187)=30.67, p<.001], alcohol use [F(187)=80.95, p<.001], binge episodes 
[F(187)=27.40, p<.001], co-use episodes [F(179)=89.03, p<.001], and co-use-binge episodes 
[F(184)=27.73, p<.001]. As expected, the ALC and MJ+ALC groups had significantly more past 
month alcohol use and binge episodes than either the MJ or HC groups while the MJ and 
MJ+ALC groups had significantly more past month cannabis use than the ALC or HC groups. 
For co-use and co-use-binge episodes, the MJ+ALC group had significantly more of each 
episode than the HC, MJ, or ALC groups. In addition, the MJ group had significantly more co-
use episodes than the HC, though did not differ significantly from the ALC group. 
In investigating co-use compared to no co-use, co-use groups differed significantly with 
past month substance use as exhibited by greater past month cannabis [F(181)=59.92, p<.001], 
alcohol [F(181)=56.69, p<.001], binge episodes [F(181)=38.84, p<.001], co-use episodes 
[F(181)=140.78, p<.001], and co-use-binge episodes [F(181)=50.97, p<.001] in the CO group 
(see Table 6). Groups also differed in maximum alcohol [F(129)=7.71, p<.01] and maximum 
cannabis use [F(132)=76.05, p<.001] in the past month in one episode, number of drinking days 
[F(180)=25.71, p<.001] and number of smoking days per month [F(131)=130.17, p<.001], 
average grams per smoking day in the past month [F(131)=119.10, p<.001]. However, CO v. NO 
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groups did not significantly differ on average drinks per drinking day in the past month 
[F(131)=2.22, p=.14]. 
Correlational analyses were run between past month substance use patterns. All substance 
use variables (alcohol use, cannabis use, binge episodes, co-use episodes, and co-use-binge 
episodes) were significantly correlated except past month binge episodes and past month 
cannabis use (see Table 7).  
Study Site. As study site is a significant predictor of most variables (see below), an effort 
was made to better understand specific site characteristics. Importantly, prior research has 
established the reliability of combining data across multiple sites so long as site is a covariate 
(Pagani et al., 2010; Fox et al., 2012; Magnotta et al., 2012). Demographics by site are listed in 
Table 8. When assessing for demographic differences by study site, age [F(188)=45.79, p<.001], 
education [F(189)=69.83, p<.001], race [x2=23.15, p=.01], and ethnicity [x2=13.86, p=.01] 
significantly differed. When the whole-sample is assessed together by substance group, there is 
no longer a statistically significant difference in these variables (see Demographics section 
above).  
Quantitative values of white matter integrity by Study Site were also pulled to see if there 
was any clear pattern (see Appendix I). In FA values, there was no clear pattern of better quality 
WM by site, as each site occasionally had higher FA values depending on the tract. In MD 
values, there was no clear pattern between UWM and McLean, but UCSD generally had a lower 
MD value. 
In addition, group differences were assessed within each site. No significant differences 
by group were found within any of the sites. The one exception to this was in McLean’s data, 
with gender being significantly different by group (F(42)=5.74, p<.01). This is consistent with 
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the broader findings of the whole combined sample, and is accounted for by covarying for 
gender in all whole-sample analyses. 
 Differences by study site were also found in substance use patterns (see Table 9). Sites 
differed in cannabis use [F(189)=9.64, p<.001], as McLean participants had significantly more 
past month cannabis use (in grams) than UWM or UCSD.  
Primary Analysis: TRACULA. 
Co-Use Data.  
FA. Primary Predictors (see Table 10). Past month cannabis use was significantly 
associated with decreased FA in the following tracts: forceps minor [beta=.18, t=2.16, p=.03, 
FDR-p=.13], left ILF [beta=.21, t=2.41, p=.02, FDR-p=.13], left uncinate [beta=.22, t=2.57, 
p=.01, FDR-p=.13], and right SLF temporal [beta=-.19, t=-2.18, p=.03, FDR-p=.13], though no 
tracts survived correction for multiple comparisons. Neither past month alcohol or co-use were 
significantly associated FA in any tract. 
Covariates. Study site was significantly associated with forceps major [beta=.25, t=3.35, 
p<.01, FDR-p<.01], forceps minor [beta=.23, t=3.25, p<.01, FDR-p<.01], left ILF [beta-.24, t=-
3.26, p<.01, FDR-p<.01], left uncinate [beta=-.21, t=-2.99, p<.01, FDR-p<.01], left ATR 
[beta=.30, t=4.22, p<.001, FDR-p<.001], right ATR [beta=.47, t=7.15, p<.001, FDR-p<.001], 
left cingulum angular bundle [beta=-.24, t=-3.32, p<.01, FDR-p<.01], right cingulum angular 
bundle [beta=-.31, t=-4.26, p<.001, FDR-p<.001], left cingulum cingulate gyrus [beta=-.22, t=-
3.04, p<.01, FDR-p<.01], right cingulum cingulate gyrus [beta=-.30, t=-4.07, p<.001, FDR-
p<.001], left SLF parietal [beta=-.23, t=-3.14, p<.01, FDR-p<.01], right SLF parietal [beta=-.30, 
t=-4.11, p<.001, FDR-p<.001], left SLF temporal [beta=-.21, t=-2.93, p<.01, FDR-p<.01]. 
Gender was significantly associated with left uncinate [beta=-.24, t=-3.53, p<.01, FDR-p=.02].  
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Prior to correction for multiple comparisons, gender was also significantly associated 
with right uncinate [beta=-.14, t=-1.80, p=.07, FDR-p=.39] and left ATR [beta=-.14, t=-2.05, 
p=.04, FDR-p=.34]. In each of these instances, males exhibited higher FA compared to females. 
MD. Primary Predictors (see Table 11). After correcting for multiple comparisons, past 
month cannabis use was significantly associated with increased MD in forceps major [beta=.14, 
t=2.18, p=.03, FDR-p=.04], left ILF [beta=.14, t=2.49, p=.014, FDR-p=.03], right ILF [beta=.15, 
t=2.70, p<.01, FDR-p=.02], right uncinate [beta=.16, t=2.39, p=.02, FDR-p=.03], left ATR 
[beta=.19, t=2.61, p=.01, FDR-p=.02], right ATR [beta=.17, t=2.41, p=.02, FDR-p=.03], left 
cingulum angular bundle [beta=16, t=2.15, p=.03, FDR-p=.04], right cingulum angular bundle 
[beta=.18, t=2.32, p=.02, FDR-p=.03], left cingulum cingulate gyrus [beta=.22, t=-2.80, p<.01, 
FDR-p=.02], right cingulum cingulate gyrus [beta=.19, t=2.32, p=.02, FDR-p=.03], left SLF 
parietal [beta=.20, t=2.87, p=.01, FDR-p=.02], right SLF parietal [beta=.22, t=3.33, p<.01, FDR-
p=.01], left SLF temporal [beta=.20, t=3.04, p<.01, FDR-p<.02], right SLF temporal [beta=.21, 
t=3.28, p<.02, FDR-p=.01]. Neither past month alcohol or co-use were significantly associated 
with MD in any tract. 
Covariates. Study site was significantly associated with forceps major [beta=-.66, t=-
11.73, p<.001, FDR-p<.001], forceps minor [beta=-.76, t=-15.81, p<.001, FDR-p<.001], left ILF 
[beta=-.76, t=-15.48, p<.001, FDR-p<.001], right ILF [beta=-.78, t=-16.60, p<.001, FDR-
p<.001], left uncinate [beta=-.63, t=-11.18, p<.001, FDR-p<.001], right uncinate [beta=-.64, t=-
11.18, p<.001, FDR-p<.001] , left ATR [beta=-.57, t=-0.37, p<.001, FDR-p<.001], right ATR  
[beta=-.56, t=-9.15, p<.001, FDR-p<.001], left cingulum angular bundle [beta=-.52, t=-8.15, 
p<.001, FDR-p<.001], right cingulum angular bundle [beta=-.51, t=-7.93, p<.001, FDR-p<.001], 
left cingulum cingulate gyrus [beta=-.41, t=-6.06, p<.001, FDR-p<.001], right cingulum 
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cingulate gyrus [beta=-.38, t=-5.47, p<.001, FDR-p<.001], left SLF parietal [beta=-.60, t=-9.95, 
p<.001, FDR-p<.001], right SLF parietal [beta=-.65, t=-11.54, p<.001, FDR-p<.001], left SLF 
temporal [beta=-.65, t=11.61, p<.001, FDR-p<.001], and right SLF temporal [beta=-.69, t=-
12.96, p<.001, FDR-p<.001].  
Gender was significantly associated with left uncinate [beta=.12, t=2.07, p=.04, FDR-
p=.64] prior to correction for multiple comparisons. 
Co-Use-Binge Data. 
FA. Primary Predictors (see Table 12). Past month cannabis use was significantly 
associated with decreased FA in the right cingulum angular bundle prior to correction for 
multiple comparisons [beta=-.28, t=-2.47, p=.02, FDR-p=.24]. Neither past month binge or co-
use-binge were significantly associated with FA in any tract. 
Covariates. Study site was significantly associated with forceps major [beta=.31, t=2.25, 
p=.03, FDR-p=.05], forceps minor [beta=.44, t=3.23, p<.01, FDR-p<.01], left ILF [beta-.36, t=-
2.71, p=.01, FDR-p=.02], left ATR [beta=.45, t=3.40, p<.01, FDR-p<.01], right ATR [beta=.67, 
t=6.18, p<.001, FDR-p<.01], left cingulum angular bundle [beta=-.38, t=-2.73, p=.01, FDR-
p=.02], right cingulum angular bundle [beta=-.43, t=-3.28, p<.01, FDR-p<.01], left cingulum 
cingulate gyrus [beta=-.31, t=-2.19, p=.03, FDR-p=.05], right cingulum cingulate gyrus [beta=-
.53, t=-3.99, p<.001, FDR-p<.01], left SLF parietal [beta=-.29, t=-2.10, p=.04, FDR-p=.05], right 
SLF parietal [beta=-.45, t=-3.33, p<.01, FDR-p<.01], and left SLF temporal [beta=-.30, t=-2.16, 
p=.03, FDR-p=.05]. 
MD. Primary Predictors (see Table 13). After correcting for multiple comparisons, past 
month cannabis use was significantly associated with increased MD in the right SLF temporal 
[beta=.11, t=3.29, p<.01, FDR-p=.02]. Prior to, but not after, corrections, past month cannabis 
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use was significantly associated with left ILF [beta=.09, t=2.20, p=.03, FDR-p=.12], right ILF 
[beta=.07, t=2.03, p=.04, FDR-p=.12], right ATR [beta=.076, t=2.031, p=.05, FDR-p=.12], right 
SLF parietal [beta=.08, t=2.57, p=.01, FDR-p=.07], left SLF temporal [beta=.12, t=2.51, p=.01, 
FDR-p=.07], and right SLF temporal [beta=.11, t=3.29, p<.01, FDR-p=.02].  
Past month co-use-binge was significantly associated with decreased MD in the left ILF  
[beta=-.11, t=-2.10, p=.04, FDR-p=.15], and right ILF [beta=-.11, t=-2.45, p=.02, FDR-p=.15] 
before correction for multiple comparisons. 
Covariates. Study site was significantly associated with forceps major [beta=-.81, t=-
11.68, p<.001, FDR-p<.001], forceps minor [beta=-.82, t=-11.17, p<.001, FDR-p<.001], left ILF 
[beta=-.89, t=-19.34, p<.001, FDR-p<.001], right ILF [beta=-.87, t=-22.12, p<.001, FDR-
p<.001], left uncinate [beta=-.83, t=-14.18, p<.001, FDR-p<.001], right uncinate [beta=-.82, t=-
16.44, p<.001, FDR-p<.001], left ATR [beta=-.84, t=-18.99, p<.001, FDR-p<.001], right ATR 
[beta=-.86 t=-20.05, p<.001, FDR-p<.001], left cingulum angular bundle [beta=-.77, t=-11.43, 
p<.001, FDR-p<.001], right cingulum angular bundle [beta=-.72, t=-9.36, p<.001, FDR-p<.001], 
left cingulum cingulate gyrus [beta=-.82, t=-13.56, p<.001, FDR-p<.001], right cingulum 
cingulate gyrus [beta=-.75, t=-11.32, p<.001, FDR-p<.001], left SLF parietal [beta=-.86, t=-
18.16, p<.001, FDR-p<.001], right SLF parietal [beta=-.87, t=-22.98, p<.001, FDR-p<.001], left 
SLF temporal [beta=-.86, t=-17.07, p<.001, FDR-p<.001], and right SLF temporal [beta=-.86, 
t=-21.90, p<.001, FDR-p<.001].  
Education was significantly associated with right ILF [beta=.09, t=2.18, p=.03, FDR-
p=.07], right uncinate [beta=.14, t=2.77, p=.01, FDR-p=.03], left ATR [beta=.12, t=2.72, p=.01, 
FDR-p=.03], right ATR [beta=.11, t=2.54, p=.01, FDR-p=.04], right cingulum cingulate gyrus 
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[beta=.16, t=2.43, p=.02, FDR-p=.04], right SLF parietal [beta=.12, t=3.20, p<.01, FDR-p=.03], 
and right SLF temporal [beta=.11, t=2.80, p=.01, FDR-p=.03].  
Prior to correction for multiple comparisons, length of abstinence was significantly 
associated with left cingulum cingulate gyrus [beta=.08, t=-1.81, p=.07, FDR-p=.24], right 
Cingulum Cingulate [beta=.09, t=1.90, p=.06, FDR-p=.24], right SLF parietal [beta=.07, t=2.66, 
p=.01, FDR-p=.14], and right SLF temporal [beta=.06, t=2.38, p=.02, FDR-p=.15]. 
Secondary Analysis: DTI-Stroop. 
Co-Use Data.  
Stroop. Within the MJ+ALC group, multiple regression analyses revealed significant 
positive relationships between MD tracts and Stroop performance, after correcting for multiple 
comparisons. Specifically, forceps major [beta=.54, t=2.72, p=.01, FDR-p=.02], left ILF 
[beta=.51, t=2.54, p=.02, FDR-p=.02], right ILF [beta=.61, t=2.59, p=.01, FDR-p=.02], right 
uncinate [beta=.49, t=2.58, p=.01, FDR-p=.02], left ATR [beta=.48, t=2.65, p=.01, FDR-p=.02], 
right ATR [beta=.45, t=2.47, p=.02, FDR-p=.02], left cingulum angular bundle [beta=.38, 
t=2.17, p=.04, FDR-p=.04], right cingulum angular bundle [beta=.39, t=2.28, p=.03, FDR-
p=.03], left cingulum cingulate gyrus [beta=.44, t=2.78, p=.01, FDR-p=.02], right cingulum 
cingulate gyrus [beta=.42, t=2.60, p=.01, FDR-p=.02], left SLF parietal [beta=.49, t=2.82, p=.01, 
FDR-p=.02], right SLF parietal [beta=.48, t=2.41, p=.02, FDR-p=.03], left SLF temporal 
[beta=.49, t=2.64, p=.01, FDR-p=.02], and right SLF temporal [beta=.50, t=2.45, p=.02, FDR-
p=.02] were significantly associated with better Stroop color-word interference performance. No 
other groups revealed significant relationships between tracts and Stroop performance. 
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Co-Use-Binge Data.  
Multiple regressions were run by group, controlling for study site, to assess whether the 
one tract that was associated with cannabis use (right SLF temporal MD) significantly related to 
Stroop performance. No significant results were revealed. 
Secondary Analysis: Substance Use Patterns-Stroop. 
Co-Use Data.  
Word reading performance was significantly negatively related to past month cannabis 
use [beta=-.23, t=-2.64, p=.01], and marginally positively related to by past month alcohol use 
[beta=.177, t=1.97, p=.05]. Color naming and color-word interference were not significantly 
associated with any primary predictors.  
Co-Use-Binge Data.  
Color naming, word reading, and color-word interference were not related to any primary 
variables. 
 
Discussion 
 The present study found a number of significant and robust relationships between past 
month cannabis use and poorer white matter integrity (measured by increased MD). However, 
contrary to our hypotheses, we did not see any influence of co-use episodes, past month alcohol 
use, past month binge episodes, or co-use-binge episodes. Secondary brain-behavior 
relationships were assessed, finding that, within only the MJ+ALC group, increased MD was 
positively associated with Stroop performance on the color-word interference subtest. Finally, 
analyses assessed the influence of substance use on Stroop performance, finding again that 
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cannabis use was the only substance significantly associated with word reading when assessed in 
the whole sample. 
 Consistent with prior findings in adolescent and emerging adult MJ users (Arnone et al., 
2008; Ashtari et al., 2009; Gruber et al., 2014; Shollenbarger et al., 2015), we found increased 
MD was associated with past month cannabis use. Our findings are consistent and robust across 
fronto-limbic and fronto-parietal networks (specifically, within the uncinate fasciculus; the 
cingulum angular bundle; the cingulum cingulate gyrus; anterior thalamic radiation; the corpus 
callosum forceps major and forceps minor; the SLF, both parietal and temporal portions; and the 
ILF tracts). Such disrupted WM may be indicative of damage to myelination due to cannabis use 
during this sensitive neurodevelopmental time period. Indeed, MJ use downregulates CB1 
activity (Hirvonen et al., 2012) and cannabinoid receptors are important for WM development 
(Molina-Holgado et al., 2002), suggesting a potential underlying mechanism of these findings.  
 This increased MD is likely an indication of altered processing that can be broken down 
by pathway types. It is interesting to hypothesize about potential functional implications of 
structural differences, though the present study assessed only one specific function. First, the 
association tracts (SLF, ILF, uncinate fasciculus, and the cingulum) connect distant regions 
within the same hemisphere and are involved in key functions such as higher cognitions, emotion 
regulation, memory, and visuospatial processing (Catani & Thiebaut de Schotten, 2012; Hua et 
al., 2009). The SLF connects the frontal, parietal, and temporal lobes, and is generally involved 
in language, visuospatial skills, and working memory. The ILF connects the occipital and 
temporal lobes, the amygdala, and the hippocampus, and is involved in functions such as 
perception, visual memory, and aspects of language. The uncinate fasciculus connection the 
anterior temporal lobe with the orbitofrontal cortex and is key to the function of the limbic 
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system. The cingulum connects the frontal, parietal, temporal, and occipital lobes to different 
portions of the cingulate cortex, leading to the limbic system and functions such as attention, 
memory, and emotion. As many of these pathways relate to fronto-limbic and cognitive 
functioning, increased dysexecutive symptoms and poorer mood regulation may be expected. 
Indeed, this is what is commonly seen in the cannabis literature; specifically, in MJ users, our 
group previously found poorer WM integrity in the bilateral uncinate to be predictive of 
increased mood and apathy symptoms (Shollenbarger et al., 2015). Others have similarly found 
cannabis users to have either decreased WM integrity in association tracts (Arnone et al., 2008; 
Ashtari et al., 2009; Delisi et al., 2006), or deficits in cognitive (Lisdahl & Price, 2012; Solowij 
et al., 2011) or emotional (McQueeny et al., 2011; Wright, Scerpella, & Lisdahl, 2016) 
functioning, or both structural and functional deficits (Maple et al., under review; Gruber et al., 
2014; Gruber et al., 2011). Admittedly, the present study did not find this relationship with 
executive functioning due directly to substance use. As this was a single measure in a secondary 
analysis, a more thorough neuropsychological battery may have revealed such relationships. 
 The commissure pathways connect the two hemispheres through the corpus callosum and 
here are divided between the corpus callosum forceps major and forceps minor (Catani & 
Thiebaut de Schotten, 2012). The forceps minor encompasses the genu and rostrum, within the 
PFC and OFC respectively. The forceps major includes the splenium in the occipital cortex, with 
some fibers reaching the parietal and temporal lobes (Catani & Thiebaut de Schotten, 2012). Our 
group (Shollenbarger et al., 2015) and others (Gruber et al., 2014) previously found increased 
MD in the forceps minor and anterior portions of the corpus callosum in cannabis users, though 
the present study did not find any results related to the forceps minor. More consistent with the 
present findings, Bava and colleagues (Bava et al., 2009) found poorer WM integrity in the 
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splenium in MJ+ALC users relative to controls, while Jacobus, Squeglia et al. (Jacobus, 
Squeglia, Bava, et al., 2013) found decreased WM in the splenium in both heavy drinkers and 
heavy drinkers-and-MJ users relative to controls. Given the role of the forceps major in 
visuospatial processing and deficits in visuospatial processing with disrupted WM in this region 
(Lunven et al., 2015) and other research suggesting disrupted visuospatial skills in MJ users 
(Huestuegge et al., 2002; Smith et al., 2010), future research should more directly assess 
potential brain-behavior relationships with the forceps major in substance using populations. 
 The projection pathways connect cortical and subcortical regions, allowing for 
communication of sensory and motor information (Catani & Thiebaut de Schotten, 2012). Here 
we found cannabis use was related to increased MD in the bilateral ATR, a region key for limbic 
functions and communication between the thalamus and PFC. Similarly, Becker and colleagues 
(2015) found young adult heavy cannabis users had reduced WM growth in a range of projection 
and other pathways over a three year period, relative to controls, and that this reduced growth 
was predictive of poorer verbal learning performance. Here again, then, it is suggested that 
underlying microstructural integrity may be altered by cannabis use, and, while not seen in the 
present study, such microstructural changes may lead to functional impairment. 
 Interestingly and contrasting our hypotheses, FA was not significantly related to 
substance use patterns. Unlike others (Ashtari et al., 2009; Delisi et al., 2006; Gruber et al., 2014; 
Shollenbarger et al., 2015) we did not find differences in FA by MJ use. FA is known to be a 
sensitive measure of overall microstructural integrity in WM as measured through directional 
cohesion, but does not offer much information related to type of change (Alexander et al., 2007). 
In contrast, MD measures the diffusion rate and free diffusion (Soares et al., 2013). Previously, 
our group has found MD to be particularly sensitive in MJ users (Shollenbarger et al., 2015), and 
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others have suggested MD is also a more sensitive measure in other clinical samples (e.g., in 
epilepsy patients; Kreilkamp, Weber, Richardson, & Keller, 2017). Perhaps MJ damages WM 
microstructure in specific ways that are lost when looking at an overall value, such as FA.   
 Also contrary to our hypotheses, we did not find any significant relationships between 
alcohol use and white matter integrity, despite previous findings (Cardenas et al., 2013; De Bellis 
et al., 2008; Lisdahl, Thayer, et al., 2013; Luciana et al., 2013; McQueeny et al., 2009; Squeglia 
et al., 2015). Further, the lack of findings around binging and co-use-binge episodes may initially 
be surprising given prior studies (Lisdahl, Thayer, et al., 2013; McQueeny et al., 2009). 
However, given the limited amount of co-use-binge in the sample (mean=1.77 in the past 
month), there may not have been enough variance to detect real change based on limited use. 
Other studies have also found results to be more robust when investigating MJ use rather than by 
alcohol use (Lisdahl & Price, 2012; Wright et al., 2016), perhaps indicating MJ is a more reliable 
predictor of such deficits. This does not negate the importance of measuring alcohol use and such 
findings as these are not always the case (e.g., Jacobus, Squeglia, Bava, et al., 2013; Lisdahl, 
Thayer, et al., 2013), but underscores the need to measure cannabis and alcohol use with careful 
quantitative techniques that enable assessment of the unique influence of each substance.  
Co-use episodes, whether or not considering alcohol binges, were not significantly 
related to any DTI outcomes once we corrected for multiple comparisons. This is in contrast to 
our expectations and to other studies that have shown acute additive cognitive deficits (Belgrave 
et al., 1979; Chait & Perry, 1994; Chesher et al., 1977; Marks & MacAvoy, 1989) and chronic 
cognitive deficits due to co-use (Winward, Hanson, et al., 2014), though none of these studies 
investigated WM differences. Given the somewhat equivocal results of human pharmacological 
studies (Chesher et al., 1976; Hartman et al., 2015; Lukas et al., 1992; Lukas & Orozco, 2001) 
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and even acute (Raemakers et al., 2011) and chronic studies (Mahmood et al., 2010), this may 
not be a surprising finding. Acutely, alcohol may increase endocannabinoid levels (Alvarez-
Jaimes, Stouffer, & Parsons, 2009; Rubio, McHugh, Fernandez-Ruiz, Bradshaw, & Walker, 
2007), which may offset the effects of MJ, even though chronic alcohol use may downregulate 
CB1 activity (Hirvonen et al., 2013). However, the nascent literature of the pharmacological 
interactive effects of MJ and alcohol, the preliminary evidence of acute deficits, and the 
equivocal findings of chronic effects (as suggested here, and in Winward, Hanson, et al., 2014) 
highlight the great need of more research in this area. These studies should consist both of 
preclinical work, as well as carefully categorizing and accounting for co-use of substances in 
human subjects. 
 As may be expected, almost all substance use measured was significantly correlated. The 
exception to this was between past month number of binge episodes and past month grams of 
cannabis used. Substance use groups may then be qualitatively different in how they approach 
substance consumption. Subjectively, when cannabis and alcohol are consumed together at low 
doses, the alcohol may be prolonging the effects of THC (Hartman et al., 2016); however, this 
relationship has not been assessed at a higher dose. Perhaps with larger dosing the effects are less 
pleasant, deterring more people from both binging and smoking marijuana together. As 
Guttmannova and colleagues suggest (Guttmannova et al., 2016), however, co-use of substances 
is a complex topic with many nuanced indicators due to policy and environmental factors, 
warranting more research in this area.  
 Limitations of the current study should be noted. Study site significantly related to most 
analyses, although it is notable that prior studies suggest that combining data across different 
sites and even scanner brands to be reliable (Fox et al., 2012; Magnotta et al., 2012; Pagani et al., 
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2010), if properly accounted through statistically covarying. The present study was designed 
with the intent to broaden external validity, including a range of demographics and substance use 
patterns across sites. Inherent in increasing external validity is reduced internal validity. Even so, 
results regarding MJ use and WM integrity are very robust, after controlling for study site and 
gender. This perhaps suggests the strong influence of cannabis use on WM integrity, despite 
differences in population makeup and locale. While every effort was made to carefully measure 
the past month of substance use, particularly for assessing same-day substance use, we were not 
able to account for whether or not the substances were used simultaneously or even within hours 
of one another. Future research should more carefully determine simultaneous use. The present 
study did not have consistent tobacco use information across study sites and, therefore, tobacco 
use was not accounted for in the present analyses, despite the potential influence of tobacco use 
on brain structure and function. Not all sites excluded for learning disabilities, and, therefore, 
performance on the Stroop task may have been influenced by potential inclusion of individuals 
with a learning disability. While brain-behavior analyses were initially examined, we only used a 
single neurocognitive task, despite the range of cognitive deficits that may be affected by 
cannabis or alcohol use; future studies should include a full neuropsychological battery. Finally 
as a cross-sectional study, causal relationships cannot be established; future studies, such as the 
Adolescent Brain and Cognitive Development (ABCD) study, are needed to assess causality. 
Conclusion. In conclusion, the present study found that greater past month cannabis use 
was associated with decreased WM integrity, as measured by MD, across fronto-parietal and 
fronto-limbic tracts. These robust findings suggest abnormal WM quality related to cannabis use, 
after accounting for study site, gender, alcohol use, and alcohol and cannabis co-use days. 
Though hypothesized, we did not find evidence for an independent or additive impact of co-
32	  
occurring same-day alcohol and cannabis use. More careful research into the combined effects of 
cannabis and alcohol, especially simultaneous use, and their potential psychopharmacological 
interactions is also needed on both preclinical and clinical levels. Given the mainstream 
popularity of cannabis use and its perceived safety and benefits, greater communication of 
potential harms to laymen and experts alike is of great need. 
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Table 1. Structural MRI Acquisition: Across IDEAA Sites 
 
Slices 
Thick-
ness 
TR TI TE FOV Flip 
Frequency 
x Phase 
Time 
UWM 176 1 mm 2.53 1100 3.39 256 12 256x256 8 min 
McLean 150 1 mm 8.20 450 3.40 240 12 256x256 9 min 
UCSD 172 1 mm 7.78 450 2.99 240 12 256x192 7 min 
Notes: Structural MRI acquisition parameters by study site. Slices: Number of slices per 
structural MRI scan; Thickness: Thickness per slice; TR: Repetition time; TI: Inversion time; 
TE: Echo time; FOV: Field of view; Flip: Tip angle; Time: Time for whole structural scan. 
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Table 2. DTI Acquisition: Across IDEAA Sites 
 
 
Slices 
Thick-
ness 
TR TE # b0 b value # directs 
Pixel 
spacing 
Avg 
UWM 60 2 mm 9300 89 7 700 48 1/1 1 
McLean 60 2 mm 9300 89 7 700 48 2/2 1 
UCSD 34 3 mm 10900 93.1 1 1500 61 1.9/1.9 1 
Notes: DTI acquisition parameters by study site. Slices: Number of slices per structural MRI 
scan; Thickness: Thickness per slice; TR: Repetition time; TE: # directs: Number of diffusion 
gradients. 
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 Table 3. Group Demographics by Substance Use Group. 
Notes: Demographic and normed Stroop performance by substance use group. Groups were not 
used for analyses, but to better approximate patterns of use and to establish appropriate 
covariates. M = mean, SD = standard deviation, *</=.05. **</=.01. ***</=.001 
 
  
 Controls 
n = 92 
MJ 
n = 33 
ALC 
n = 27 
MJ+ALC 
n = 39 
 % or  
M (SD) Range 
% or  
M (SD) Range 
% or  
M (SD) Range 
% or  
M (SD) Range 
Age 19.93 (2.73) 16-25 
19.96 (2.59) 
16-27 
21.17 (2.30) 
17.25-25 
19.75 (2.48) 
16-26 
Education 13.39 (2.52) 9-21 
13.02 (1.69) 
11-16 
14.33 (1.78) 
11-17 
13.04 (2.07) 
10-18 
Gender* 
(% Female) 50% 24% 48% 28% 
Race 
(% Caucasian) 71% 76% 74% 79% 
Ethnicity 
(% Hispanic) 15% 12% 15% 15% 
Left-Handed n = 1 n = 1 n = 0  n = 1 
Stroop – Color .57 (.67) -2.00-2.00 
.42 (.61) 
-1.00-1.67 
.59 (.61)  
-1.33-2.00 
.47 (.63) 
-1.33-1.50 
Stroop – Word .74 (.74) -1.67-2.00 
.35 (.91) 
-1.45-1.67 
.72 (.60)  
-.67-1.67 
.59 (.92)  
-2.33-2.18 
Stroop - 
Interference 
.92 (.74) 
-.67-2.33 
.90 (.82) 
-1.07-2.22 
1.03 (.53) 
-.33-1.67 
.91 (.80) 
-2.00-3.48 
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Table 4. CO and NO Group Demographic Information. 
 No-CO 
n = 115 
CO 
n = 68 
 % or  
M (SD) Range 
% or  
M (SD) Range 
Age 20.19 (2.68) 16-25 
19.96 (2.54) 
16-27 
Education 13.59 (2.38) 9-21 
12.99 (1.92) 
10-18 
Gender 
(% Female) 47%  34%  
Race 
(% Caucasian) 74%  71%  
Ethnicity 
(% Hispanic) 12%  21%  
Left-Handed n = 2 n = 1 
Stroop – 
Color 
.58 (.62)  
-2.00-2.00 
.41 (.69) 
-1.33-2.00 
Stroop – 
Word 
.69 (.72) 
-1.67-2.00 
.50 (.90)  
-2.33-2.18 
Stroop - 
Interference 
.98 (.68) 
-.67-2.33 
.81 (.83) 
-2.00-2.48 
Notes: Demographic information by co-use and no-co-use groups. These groups were not use in 
any analyses, but were explored for qualitative purposes to better understand the use patterns of 
those who co-use compared to those who do not. M = mean, SD = standard deviation, *</=.05. 
**</=.01. ***</=.001. 
 
  
37	  
Table 5. Past Month Substance Use by Substance Use Group. 
Notes: Past month substance use by substance group in standardized units. Groups were not used 
for analyses, but to better approximate patterns of use and to establish appropriate covariates. 
Alcohol: Standard drinks; 1 ounce of liquor, 4 ounces of wine, 12 ounces of beer. Cannabis: 
grams. Co-Use: Co-occurring alcohol and cannabis, days of co-use. Binge: Number of binge 
drinking episodes; ≥4 drinks for females, ≥5 for males in one drinking occasion, not limited by 
hours. Co-Use-Binge: Co-occurring alcohol and cannabis, days of co-use-binge; binging defined 
as ≥4 drinks for females, ≥5 for males in one drinking occasion, not limited by hours. M = mean, 
SD = standard deviation, *</=.05. **</=.01. ***</=.001. 
 
  
 Controls 
n = 92 
MJ 
n = 33 
ALC 
n = 27 
MJ+ALC 
n = 39 
 M (SD) Range M (SD) Range M (SD) Range M (SD) Range 
Alcohol*** 4.59 (5.47) 0-19.35 
7.12 (5.02) 
0-17.16 
41.37 (21.85) 
23.57-107.42 
50.88 (33.72) 
21.43-167.14 
Cannabis*** .06 (.27) 0-1.94 
21.98 (29.77) 
2.36-139.91 
.38 (.64) 
0-1.94 
20.74 (18.19) 
2.09-90.89 
Binge*** .28 (.60) 0-2.90 
.12 (.42) 
0-1.94 
3.07 (3.34) 
0-11.61 
3.85 (4.47) 
0-15 
Co-Use*** .04 (.21) 0-1.07 
1.87 (2.22) 
0-8.58 
.59 (1.03) 
0-3.87 
7.26 (4.65) 
0-17.16 
Co-Use-
Binge*** 
.01 (.11) 
0-1.07 
.44 (.94) 
0-4.29 
.48 (.80) 
0-2.90 
3.63 (4.56) 
0-17.14 
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Table 6. CO and NO Group Past Month Substance Use Information. 
 No-CO 
n = 115 
CO 
n = 68 
 M (SD) Range M (SD) Range 
Alcohol*** 9.15 (12.30)  0-61.94 
37.21 (35.48) 
.99-167.14 
Cannabis*** .98 (3.42)  0-20.74 
16.98 (22.40)  
.08-139.91 
Binge*** .49 (1.13)  0-5.81 
2.99 (4.08) 
0-15 
Co-Use*** 0 (0)  0-0 
4.77 (4.32) 
.97-17.16 
Co-Use-Binge*** 0 (0)  0-0 
2.47 (3.72) 
0-17.14 
Notes: Past month substance use by co-use and no-co-use groups in standardized units. These 
groups were not use in any analyses, but were explored for qualitative purposes to better 
understand the use patterns of those who co-use compared to those who do not. Alcohol: 
Standard drinks; 1 ounce of liquor, 4 ounces of wine, 12 ounces of beer. Cannabis: grams. Co-
Use: Co-occurring alcohol and cannabis, days of co-use. Binge: Number of binge drinking 
episodes; ≥4 drinks for females, ≥5 for males in one drinking occasion, not limited by hours. Co-
Use-Binge: Co-occurring alcohol and cannabis, days of co-use-binge; binging defined as ≥4 
drinks for females, ≥5 for males in one drinking occasion, not limited by hours. M = mean, SD = 
standard deviation, *</=.05. **</=.01. ***</=.001. 
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Table 7. Correlations Between Substance Use Patterns.  
Notes: Correlations of substance use for all participants. Each variable is for past month 
substance use in standard units or episodes. aPast month number of standard alcohol drinks; bpast 
month number of grams of cannabis used; cpast month number of episodes using both alcohol 
and cannabis, regardless of amount used; dpast month number of binge episodes (=/>4 standard 
drinks for females, =/>5 standard drinks for males, on one drinking occasion); epast month 
number of episodes using both binge-level alcohol and cannabis. M = mean, SD = standard 
deviation, *</=.05. **</=.01. ***</=.001. 
  
Variables 1 2 3 4 5 
1. Alcohola -     
2. Cannabisb .30*** -    
3. Co-Usec .60*** .54*** -   
4. Binged .82*** .14 .43*** -  
5. Co-Use-Bingee .61*** .29*** .68*** .70*** - 
M 19.68 8.33 1.77 1.36 .88 
SD 26.75 18.14 3.50 2.85 2.51 
Range 0-167.14 0-139.91 0-17.16 0-15 0-17.14 
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Table 8. Demographics by Study Site. 
 
 UWM 
n = 75 
UCSD 
n = 59 
McLean 
n = 58 
 % or  
M (SD) Range 
% or  
M (SD) Range 
% or  
M (SD) Range 
Age*** 21.23 (2.53) 16-26 
17.83 (.81) 
16.25-19 
20.83 (2.52) 
16-27 
Education*** 14.34 (2.17) 9-21 
11.20 (.76) 
10-13 
14.30 (1.70) 
11-18 
Gender 
(% Female) 47% 36% 40% 
Race* 
(% Caucasian) 68% 68% 88% 
Ethnicity ** 
(% Hispanic) 12% 27% 5% 
Stroop – Color .74 (.66)  
-2.00-2.00 
.18 (.65)  
-1.33-1.00 
.50 (.46)  
-.50-1.50 
Stroop – Word .86 (.74)  
-1.67-2.00 
.36 (.81)  
-2.33-1.33 
.54 (.80)  
-1.59-2.18 
Stroop - Interference 1.06 (.67)  
-.67-2.00 
.51 (.76)  
-2.00-2.00 
1.08 (.68)  
-1.07-2.48  
Notes: Demographics and normed Stroop performance by study site. M = mean, SD = standard 
deviation, *</=.05. **</=.01. ***</=.001 
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Table 9. Past Month Substance Use by Study Site. 
 UWM 
n = 75 
UCSD 
n = 59 
McLean 
n = 58 
 M (SD) Range M (SD) Range M (SD) Range 
Length of Abstinence 
(Days) 
29.38 (23.44) 
5-197 
26.69 (2.63) 
12-28 -- 
Cannabis*** 3.36 (8.17) 0-47.42 
6.70 (12.99) 
0-60.54 
16.43 (27.23) 
0-139.91 
Alcohol 19.29 (26.87) 0-132.58 
21.54 (32.82) 
0-167.14 
18.26 (18.76) 
0-98.67 
Binge 1.73 (2.96) 0-11.61 
2.20 (3.56) 
0-15 
0 (0) 
0-0 
Co-Use 1.14 (2.73) 0-15.48 
2.25 (3.95) 
0-17.14 
2.17 (3.87) 
0-17.16 
Co-Use-Binge .44 (1.19) 0-5.81 
2.25 (3.95) 
0-17.14 
0 (0) 
0-0 
Notes: Past month substance use by study site. Alcohol: Standard drinks; 1 ounce of liquor, 4 
ounces of wine, 12 ounces of beer. Cannabis: grams. Co-Use: Co-occurring alcohol and 
cannabis, days of co-use. Binge: Number of binge drinking episodes; ≥4 drinks for females, ≥5 
for males in one drinking occasion, not limited by hours. Co-Use-Binge: Co-occurring alcohol 
and cannabis, days of co-use-binge; binging defined as ≥4 drinks for females, ≥5 for males in 
one drinking occasion, not limited by hours. M = mean, SD = standard deviation, *</=.05. 
**</=.01. ***</=.001 
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Table 10. Co-Use Data in FA  
 
Tract Variable p FDR-p 
Forceps Major -- - - 
Forceps Minor Cannabis .03* .128 
Left ILF Cannabis .017* .128 
Right ILF -- - - 
Left Uncinate Cannabis .011* .128 
Right Uncinate -- - - 
Left ATR -- - - 
Right ATR -- - - 
Left Cingulum 
Angular Bundle 
-- - - 
Right Cingulum 
Angular Bundle 
-- - - 
Left Cingulum 
Cingulate Gyrus 
-- - - 
Right Cingulum 
Cingulate Gyrus 
-- - - 
Left SLF Parietal  -- - - 
Right SLF Parietal -- - - 
Left SLF Temporal -- - - 
Right SLF Temporal Cannabis .030* .128 
Multiple regression FA results for co-use data with cannabis, alcohol, and co-use cannabis and 
alcohol days as primary variables; covarying for gender and study site. FDR-p = corrected for 
multiple comparisons. *p<.05 
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Table 11. Co-Use Data in MD. 
 
Tract Variable p FDR-p 
Forceps Major Cannabis .031* .038* 
Forceps Minor -- - - 
Left ILF Cannabis .014* .028* 
Right ILF Cannabis .008* .021* 
Left Uncinate -- - - 
Right Uncinate Cannabis .018* .028* 
Left ATR Cannabis .010* .023* 
Right ATR Cannabis .017* .028* 
Left Cingulum 
Angular Bundle 
Cannabis .033* .038* 
Right Cingulum 
Angular Bundle 
Cannabis .021* .028* 
Left Cingulum 
Cingulate Gyrus 
Cannabis .006* .019* 
Right Cingulum 
Cingulate Gyrus 
Cannabis .021* .028* 
Left SLF Parietal  Cannabis .005* .019* 
Right SLF Parietal Cannabis .001* .008* 
Left SLF Temporal Cannabis .003* .016* 
Right SLF Temporal Cannabis .001* .008* 
Multiple regression MD results for co-use data with cannabis, alcohol, and co-use cannabis and 
alcohol days as primary variables; covarying for gender and study site. FDR-p = corrected for 
multiple comparisons. *p<.05 
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Table 12. Co-Use-Binge Data in FA 
 
Tract Variable p FDR-p 
Forceps Major -- - - 
Forceps Minor -- - - 
Left ILF -- - - 
Right ILF -- - - 
Left Uncinate -- - - 
Right Uncinate -- - - 
Left ATR -- - - 
Right ATR -- - - 
Left Cingulum Angular 
Bundle 
-- - - 
Right Cingulum 
Angular Bundle 
Cannabis .015* .240 
Left Cingulum 
Cingulate Gyrus 
-- - - 
Right Cingulum 
Cingulate Gyrus 
-- - - 
Left SLF - Parietal  -- - - 
Right SLF - Parietal -- - - 
Left SLF - Temporal -- - - 
Right SLF - Temp -- - - 
Multiple regression results for co-use data with cannabis, binge episodes, and co-use-binge 
cannabis and binge days as primary variables; covarying for education, length of abstinence, and 
study site. FDR-p = corrected for multiple comparisons. *p<.05 
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Table 13. Co-Use-Binge Data in MD 
 
Tract Variable p FDR-p 
Forceps Major -- - - 
Forceps Minor -- - - 
Left ILF Cannabis 
Co-Use-Binge 
.030* 
.038* 
.12 
.152 
Right ILF Cannabis 
Co-Use-Binge 
.044* 
.02* 
.12 
.152 
Left Uncinate -- - - 
Right Uncinate -- - - 
Left ATR -- - - 
Right ATR Cannabis .045* .12 
Left Cingulum Angular 
Bundle 
-- - - 
Right Cingulum Angular 
Bundle 
-- - - 
Left Cingulum Cingulate 
Gyrus 
-- - - 
Right Cingulum Cingulate 
Gyrus 
-- - - 
Left SLF - Parietal  -- - - 
Right SLF - Parietal Cannabis .012* .069 
Left SLF - Temporal Cannabis 
Co-Use-Binge 
.013* 
.036* 
.069 
.152 
Right SLF - Temp Cannabis 
Co-Use-Binge 
.001* 
.022* 
.016* 
.152 
Multiple regression results for co-use data with cannabis, binge episodes, and co-use-binge 
cannabis and binge days as primary variables; covarying for education, length of abstinence, and 
study site. FDR-p = corrected for multiple comparisons. *p<.05 
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Appendix: DTI values by Study Site 
 
FA 
 
 UWM McLean UCSD 
Tract M (SD) Range M (SD) Range M (SD) Range 
Forceps Major .508 (.028) .441-.564 .559 (.060) .407-.670 .541 (.070) .354-.706 
Forceps Minor .390 (.049) .237-.539 .447 (.056) .337-.588 .426 (.071) .242-.533 
Left ILF .452 (.024) .387-.503 .489 (.043) .384-.624 .428 (.037) .228-.473 
Right ILF .459 (.026) .387-.522 .497 (.041) .405-.595 .450 (.040) .234-.519 
Left Uncinate .367 (.021) .320-.438 .398 (.044) .321-.525 .345 (.053) .198-.417 
Right Uncinate .369 (.021) .317-.418 .392 (.039) .317-.496 .363 (.045) .172-.430 
Left ATR .377 (.019) .337-.411 .400 (.035) .326-.486 .398 (.023) .335-.461 
Right ATR .381 (.018) .347-.427 .369 (.035) .308-.461 .424 (.030) .352-.501 
Left Cingulum 
Angular Bundle 
.332 (.030) .264-.420 .283 (.050) .197-.437 .309 (.051) .173-.404 
Right Cingulum 
Angular Bundle 
.334 (.036) .200-.438 .279 (.050) .175-.383 .300 (.050) .168-.396 
Left Cingulum 
Cingulate Gyrus 
.546 (.055) .386-.646 .491 (.077) .331-.730 .519 (.039) .444-.593 
Right Cingulum 
Cingulate Gyrus 
.502 (.046) .382-.634 .463 (.068) .331-.618 .469 (.037) .398-.551 
Left SLF Parietal  .419 (.029) .350-.476 .418 (.041) .322-.506 .400 (.039) .228-.482 
Right SLF Parietal .444 (.032) .352-.530 .411 (.044) .321-.511 .420 (.032) .362-.498 
Left SLF Temporal .436 (.025) .380-.503 .454 (.038) .363-541 .415 (.051) .230-.488 
Right SLF Temporal .437 (.028) .363-.523 .413 (.040) .323-.515 .426 (.038) .253-.512 
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MD 
 
 UWM McLean UCSD 
Tract M (SD) Range M (SD) Range M (SD) Range 
Forceps Major .000823 (.000044) 
.000742-.001060 
.000871 (.000079) 
.000758-.001145 
.000634 (.000066) 
.000552-.000887 
Forceps Minor .000901 (.000087) 
.000794-.001238 
.000864 (.000089) 
.000756-.001183 
.000651 (.000053) 
.000545-.000834 
Left ILF .000811 (.000087) 
.000748-.000886 
.000847 (.000051) 
.000744-.000992 
.000617 (.0000386) 
.000558-.000797 
Right ILF .000814 (.000029) 
.000750-.000900 
.000841 (.000044) 
.000761-.000954 
.000614 (.000033) 
.000552-.000724 
Left Uncinate .000814 (.000030) 
.000738-.000877 
.000867 (.000081) 
.000747-.001083 
.000646 (.000043) 
.000584-.000763 
Right Uncinate .000812 (.000030) 
.000758-.000881 
.000881 (.000080) 
.000772-.001087 
.000635 (.000038) 
.000588-.000815 
Left ATR .000748 (.000027) 
.000696-.000809 
.000843 (.000085) 
.000717-.001148 
.000585 (.000028) 
.000527-.000670 
Right ATR .000755 (.000029) 
.000706-.000831 
.000864 (.000088) 
.000724-.001133 
.000584 (.000028) 
.000529-.000670 
Left Cingulum 
Angular Bundle 
.000825 (.000042) 
.000703-.000905 
.000936 (.000115) 
.000728-.001168 
.000661 (.000049) 
.000596-.000891 
Right Cingulum 
Angular Bundle 
.000823 (.000050) 
.000721-.000970 
.000928 (.000115) 
.000756-.001174 
.000664 (.000050) 
.000593-.000867 
Left Cingulum 
Cingulate Gyrus 
.000690 (.000038) 
.000605-.00792 
.000863 (.000011) 
.000676-.001093 
.000546 (.000028) 
.000492-.000635 
Right Cingulum 
Cingulate Gyrus 
.000682 (.000038) 
.000575-.000779 
.000853 (.000103) 
.000680-.001067 
.000556 (.000030) 
.000502-.000642 
Left SLF Parietal  .000719 (.000026) 
.000659-.000797 
.000816 (.000058) 
.000721-.000947 
.000564 (.000031) 
.000510-.000670 
Right SLF Parietal .000726 (.000026) 
.000683-.000797 
.000809 (.000054) 
.000724-.000938 
.000556 (.000023) 
.000514-.000617 
Left SLF Temporal .000735 (.000026) 
.000679-.000803 
.000809 (.000056) 
.000718-.000958 
.000570 (.000038) 
.000510-.000695 
Right SLF Temporal .000734 (.000026) 
.000685-.000820 
.000799 (.000047) 
.000714-.000910 
.000561 (.000028) 
.000511-.000663 
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Nazarene	  University	  Honors	  Conference,	  San	  Diego,	  CA.	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POSTER PRESENTATIONS (listed as Wright, N.E. or Wade, N.E.) 
 
	  
1. Wallace,	  A.L.,	  Wright,	  N.E.,	  Gilbart,	  E.R.,	  &	  Lisdahl,	  K.M.	  (June,	  2017).	  ADHD	  symptoms	  
and	  marijuana	  exposure	  predict	  sustained	  attention	  accuracy.	  Poster	  presented	  at	  the	  
College	  on	  Problems	  of	  Drug	  Dependence	  in	  Montreal,	  Canada.	  
2. Gilbart,	  E.R.,	  Wright,	  N.E.,	  Lisdahl,	  K.L.	  (February,	  2017).	  Marijuana	  Use,	  Aerobic	  Fitness,	  
Mood,	  and	  Disinhibition	  in	  Emerging	  Adults.	  Poster	  presented	  at	  the	  annual	  
International	  Neuropsychological	  Society	  conference	  in	  New	  Orleans,	  LA.	  
3. Wright,	  N.E.,	  Kangsier,	  M.E.,	  Vitucci,	  S.,	  Gill,	  E.,	  &	  Lisdahl,	  K.M.	  (June,	  2016).	  Adolescent	  
and	  young	  adult	  alcohol,	  marijuana,	  and	  gender	  effects	  on	  depression,	  anxiety,	  and	  
apathy.	  Poster	  presented	  at	  the	  Research	  Society	  on	  Alcoholism	  conference	  in	  New	  
Orleans,	  LA.	  	  
4. Wright,	  N.E.,	  Scerpella,	  D.,	  &	  Lisdahl,	  K.M.	  (February,	  2016).	  Young	  adult	  marijuana	  use	  
and	  gender	  effects	  on	  frontolimbic	  function:	  Depression,	  anxiety,	  impulsivity,	  and	  
executive	  dysfunction.	  Poster	  presented	  at	  the	  annual	  International	  Neuropsychological	  
Society	  conference	  in	  Boston,	  MA.	  
5. Wright,	  N.E.	  &	  Lisdahl,	  K.M.	  (November,	  2015).	  The	  potential	  influence	  of	  5-­‐HTTLPR	  
Genotype,	  Gender	  and	  Ecstasy	  use	  on	  Depressive	  Symptoms	  in	  Adolescent	  and	  Emerging	  
Adults.	  Poster	  presented	  at	  the	  Society	  for	  Neuroscience	  conference	  in	  Chicago,	  Illinois.	  
6. Wright,	  N.E.,	  Padula,	  C.B.,	  Anthenelli,	  R.M.,	  Nelson,	  E.,	  Eliassen,	  J.,	  Lisdahl,	  K.M.	  (June,	  
2015).	  Amygdala	  hyperactivity	  and	  functional	  connectivity	  during	  a	  stress	  task	  in	  alcohol	  
dependent	  individuals.	  Poster	  presented	  at	  the	  Research	  Society	  on	  Alcoholism,	  San	  
Antonio,	  Texas.	  
7. Maple,	  K.E.,	  Wright,	  N.E.,	  &	  Lisdahl,	  K.M.	  (June,	  2014).	  Marijuana	  use	  and	  FAAH	  
genotype	  predict	  sleep	  quality	  in	  adolescent	  and	  emerging	  adults.	  Poster	  presented	  at	  
the	  College	  on	  Problems	  of	  Drug	  Dependence,	  San	  Juan,	  Puerto	  Rico.	  
8. Wright,	  N.E.,	  Shollenbarger,	  S.G.,	  &	  Lisdahl,	  K.M.	  (June,	  2013).	  	  5-­‐HTTLPR	  genotype,	  
gender	  and	  ecstasy	  use	  interact	  to	  predict	  verbal	  memory	  in	  adolescent	  and	  emerging	  
adults.	  Presented	  at	  The	  International	  Women’s	  and	  Children’s	  Health	  and	  Gender	  
Group,	  San	  Diego,	  CA.	  
9. Shollenbarger,	  S.,	  Wright,	  N.E.,	  Browning,	  E.,	  Lisdahl,	  K.	  (August,	  2013).	  Executive	  
functioning	  in	  adolescent	  and	  emerging	  adult	  poly-­‐substance	  users.	  Poster	  presented	  at	  
The	  American	  Psychological	  Association,	  Honolulu,	  HI.	  
10. Higley,	  A.E.,	  Wright,	  N.E.,	  Tibbs,	  J.J.,	  Quello,	  S.,	  &	  Mason,	  B.J.	  (June,	  2012).	  	  Stress	  and	  
craving:	  Predicting	  alcohol	  treatment	  outcomes	  using	  a	  human	  laboratory	  paradigm	  of	  
interpersonal	  stress	  induction.	  Presented	  at	  Research	  Society	  on	  Alcoholism,	  San	  
Francisco,	  CA.	  
11. Wright,	  N.E.	  &	  Oakes	  Mueller,	  R.	  (April,	  2012).	  	  The	  role	  of	  disgust	  in	  predicting	  prosocial	  
behavior.	  	  Presented	  at	  Western	  Psychological	  Association,	  San	  Francisco,	  CA.	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INVITED TALKS 
 
	  
1. Wright,	  N.E.	  (2016,	  March).	  Clinical	  Cannabinoid	  Gems	  for	  the	  Practitioner	  from	  
Research	  Data.	  Invited	  talk	  to	  the	  pre-­‐doctoral	  Psychology	  Interns	  and	  the	  Mental	  
Health	  Department	  at	  the	  Zablocki	  VA	  Medical	  Center,	  Milwaukee,	  WI.	  
2. Wright,	  N.E.	  (2015,	  March).	  Marijuana,	  Brain	  Development,	  and	  the	  University.	  Invited	  
talk	  to	  the	  undergraduate	  students	  at	  Mount	  Vernon	  Nazarene	  University,	  Mount	  
Vernon,	  OH.	  
	   	  
 
RESEARCH EXPERIENCE 
	  
	  
2012-­‐Present	   Graduate	  Research	  Assistant,	  Brain	  Imaging	  and	  Neuropsychology	  (BraIN)	  Lab,	  
University	  of	  Wisconsin-­‐Milwaukee,	  P.I.:	  Krista	  Medina	  Lisdahl,	  Ph.D.	  
	  
(1) Assist	  in	  running	  a	  three-­‐week	  study	  of	  the	  effects	  of	  marijuana	  use	  on	  
adolescent	  and	  emerging	  adult	  brain	  development,	  as	  well	  as	  the	  potential	  
influence	  of	  factors	  such	  as	  gender,	  alcohol	  use,	  life	  stress,	  and	  exercise.	  
Additional	  longitudinal	  effects	  at	  2-­‐year	  follow-­‐up	  are	  also	  being	  assessed.	  	  
Funding	  Source:	  R01	  DA030354,	  NIDA;	  P.I.:	  Lisdahl,	  K.M.	  
	  
(2) Integrate	  neuropsychological	  and	  psychosocial	  data	  across	  five	  sites	  
(University	  of	  Wisconsin-­‐Milwaukee,	  University	  of	  California	  San	  Diego,	  
University	  of	  New	  Mexico,	  University	  of	  Texas	  Dallas,	  and	  Harvard	  University)	  
for	  use	  in	  the	  Imaging	  Data	  in	  Emerging	  Adults	  with	  Addiction	  (IDEAA)	  
Consortium.	  	  
Funding	  Source:	  R01DA030354-­‐03S1,	  NIDA;	  P.I.s:	  Lisdahl,	  K.M.,	  Gruber,	  S.,	  
Tapert,	  S.,	  &	  	  
Filbey,	  F.	  
	  
(3) Help	  run	  baseline	  data	  collection	  at	  the	  University	  of	  Wisconsin-­‐Milwaukee	  
site	  in	  the	  Adolescent	  Brain	  and	  Cognitive	  Development	  (ABCD)	  study,	  a	  10-­‐
year	  longitudinal	  study	  recruiting	  11,500	  kids	  at	  approximately	  20	  sites	  
across	  the	  country.	  	  
Funding	  Source:	  DA041025-­‐01U01,	  NIDA;	  P.I.:	  Lisdahl,	  K.M.	  
	   	  
2014-­‐2017	   Research	  Consultant,	  MAPPS	  Project,	  University	  of	  Wisconsin-­‐Milwaukee,	  P.I.:	  
Davies,	  W.	  Hobey	  Davies,	  Ph.D.	  	   	  
Consult	  on	  a	  project	  assessing	  the	  feasibility	  of	  a	  behavioral	  intervention	  parents	  
can	  use	  to	  prevent	  the	  initiation	  of	  alcohol	  use	  by	  adolescents.	  	  
	  
2016-­‐2017	   Research	  Assistant,	  Atwater	  Standing	  Desks	  Project,	  University	  of	  Wisconsin-­‐
Milwaukee,	  P.I.:	  Ann	  Swartz,	  Ph.D.	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Assisted	  in	  a	  year-­‐long	  study	  of	  in	  a	  community	  elementary	  school	  to	  determine	  
possible	  outcomes	  of	  standing	  desks	  compared	  to	  sitting	  desks	  on	  executive	  
function,	  learning,	  attention,	  postural	  stability,	  and	  physical	  activity	  levels.	  	  
	  
Funding	  Source:	  SAFCO	  Products	  Company	  
	  
2011-­‐2012 Research	  Intern,	  Laboratory	  of	  Clinical	  Psychopharmacology,	  Committee	  on	  the	  
Neurobiology	  of	  Addictive	  Disorders,	  The	  Pearson	  Center	  for	  Alcoholism	  and	  
Addiction	  Research,	  The	  Scripps	  Research	  Institute,	  P.I.:	  Barbara	  Mason,	  Ph.D.	  
	  
Assisted	  in	  conduction	  of	  12-­‐week	  long	  clinical	  trial	  for	  alcohol	  dependence,	  
including	  neuropsychological	  assessment	  and	  a	  cue-­‐	  and	  stress-­‐induced	  craving	  
paradigm.	  	  
	  
Funding	  Source:	  MERIT	  Award	  for	  Medication	  Development,	  National	  Institutes	  
of	  Health;	  P.I.:	  Mason,	  B.J.,	  Ph.D.	  
 
TEACHING EXPERIENCE 
	  
	  
Instructor	  
2015-­‐2016	   PSYCH433	  Neuropsychology,	  University	  of	  Wisconsin—Milwaukee	  
	  
Teaching	  Assistant	  
2014-­‐2015	   Graduate	  Clinical	  Assessment	  Practicum,	  University	  of	  Wisconsin—Milwaukee	  
2013-­‐2014	   Psychology	  of	  Women	  (PSYCH320),	  University	  of	  Wisconsin—Milwaukee	  
2012	   Introduction	  to	  Psychology	  (PSYCH101),	  U-­‐Pace	  Online	  Course,	  University	  of	  
Wisconsin—Milwaukee	  
	  
Guest	  Lecturer	   	   	   	   	   	   	   	   	  
2016	   PSYCH912	  Developmental	  Psychopathology	  (Graduate	  Level).	  Substance	  Use	  
Disorders.	  University	  of	  Wisconsin-­‐Milwaukee	  
2016	   CON770	  Psychopathology.	  Dissociative	  Disorders.	  Mount	  Mary	  University	  
2014	   PYC3500	  Abnormal	  Psychology.	  	  Substance	  Use	  Disorders.	  Carthage	  College	  
2013	   PYC3500	  Abnormal	  Psychology.	  	  Substance	  Use	  Disorders.	  Carthage	  College	  
2012-­‐2013	   PSYCH433	  Neuropsychology.	  Neurological	  Disorders.	  University	  of	  Wisconsin—
Milwaukee	  
2011	   PSY308	  Development	  Psychology.	  	  Brain	  Development	  and	  Neuroplasticity.	  	  Point	  
Loma	  Nazarene	  University	  
2011	   PSY301	  Physiological	  and	  Neuropsychology.	  Brain	  Plasticity	  and	  Recovery.	  Point	  
Loma	  Nazarene	  University	  
 
CLINICAL TRAINING AND EXPERIENCE 
 
2017-­‐Present	   Psychology	  Intern,	  VA	  Puget	  Sound	  American	  Lake	  
• Complete	  three	  4-­‐month	  rotations	  over	  the	  course	  of	  the	  year:	  (1)	  Mental	  
Health	  Neuropsychology,	  with	  a	  CBT-­‐Insomnia	  intervention	  minor;	  (2)	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Geriatric	  Research,	  Education,	  and	  Clinical	  Care	  (GRECC);	  (3)	  Residential	  
Substance	  Treatment.	  
	  
In	  Mental	  Health	  Neuropsychology,	  conducted	  full	  neuropsychological	  
evaluations,	  from	  interview	  through	  feedback	  and	  report,	  across	  the	  lifespan	  
and	  med-­‐neuro	  and	  psych-­‐neuro	  referrals.	  Additionally,	  co-­‐lead	  a	  CBT	  for	  
Insomnia	  group.	  
	  
Additional	  rotations	  have	  not	  yet	  begun	  (GRECC:	  December	  18-­‐April	  6;	  
Residential	  Substance	  Treatment:	  April	  8-­‐July	  27).	  
	  
2016-­‐2017	   Practicum	  Student,	  Medical	  College	  of	  Wisconsin	  Pediatric	  Neuropsychology	  
Department	  
• Completed	  outpatient	  neuropsychological	  assessments	  with	  children	  
between	  the	  ages	  of	  6	  and	  17,	  including	  intake	  interview,	  testing,	  report	  
writing,	  and	  feedback	  sessions.	  
	  
2014-­‐2017	   Practicum	  Student,	  Therapy	  Practicum	  in	  the	  UWM	  Psychology	  Clinic	  
• Practice	  evidence-­‐based	  outpatient	  treatments	  for	  couple’s	  therapy	  
(Integrative	  Behavioral	  Couples	  Therapy)	  and	  children’s	  anxiety	  disorders	  
(Coping	  Cat)	  with	  members	  of	  the	  community.	  
	  
2015-­‐2016	   Practicum	  Student,	  Milwaukee	  VA	  Neuropsychology	  Department	  
• Completed	  full	  neuropsychological	  assessments,	  with	  one	  to	  two	  cases	  seen	  
and	  reports	  written	  per	  week.	  Conducted	  brief	  cognitive	  screenings	  in	  the	  
Neurology	  Clinic	  and	  participated	  in	  rounds	  with	  the	  Neurology	  team.	  	  
2014-­‐2015	   Peer	  Supervisor,	  Peer	  Supervision	  of	  Assessments	  in	  the	  UWM	  Psychology	  Clinic	  
• Live	  supervised	  child	  and	  adult	  learning	  disability	  assessment	  sessions	  for	  
second	  year	  clinical	  psychology	  graduate	  students.	  Supervised	  first	  year	  
clinical	  psychology	  graduate	  student’s,	  observing	  clinical	  interviews,	  
assessments,	  and	  teaching	  them	  the	  common	  factors	  of	  therapy.	  	  
	  
2013-­‐2014	   Practicum	  Student,	  Assessment	  Practicum	  in	  the	  UWM	  Psychology	  Clinic	  
• Conducted	  learning	  disability	  and	  psychodiagnostic	  assessments	  using	  a	  
range	  of	  cognitive,	  achievement,	  and	  neuropsychological	  measures,	  as	  well	  
as	  symptom	  and	  behavioral	  questionnaires.	  Completed	  clinical	  interviews,	  
reports,	  and	  feedback	  sessions.	  	  
	  
ACADEMIC AWARDS AND HONORS 
	  
	  
2016-­‐2017	   Distinguished	  Dissertation	  Fellowship,	  a	  competitive	  merit-­‐based	  award	  from	  the	  
University	  of	  Wisconsin-­‐Milwaukee	  Graduate	  School	  
2016	   Research	  Society	  on	  Alcoholism	  Student	  Merit	  Award,	  for	  the	  2016	  RSA	  
Conference,	  funded	  by	  the	  National	  Institute	  on	  Alcohol	  Abuse	  and	  Alcoholism	  
(NIAAA)	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2015-­‐2016	   Distinguished	  Graduate	  Student	  Fellowship,	  a	  competitive	  merit-­‐based	  award	  
from	  the	  University	  of	  Wisconsin-­‐Milwaukee	  Graduate	  School	  
2015	   Research	  Society	  on	  Alcoholism	  Student	  Merit	  Award,	  for	  the	  2015	  RSA	  
Conference,	  funded	  by	  the	  National	  Institute	  on	  Alcohol	  Abuse	  and	  Alcoholism	  
(NIAAA)	  
2013	   Division	  40	  (Clinical	  Neuropsychology)	  Student	  Poster	  Award,	  from	  APA	  Division	  
40	  at	  the	  2013	  APA	  conference	  
2012-­‐2014	   Chancellor’s	  Award,	  recipient	  of	  merit-­‐based	  award	  from	  the	  University	  of	  
Wisconsin-­‐Milwaukee	  Graduate	  School	  
PROFESSIONAL AFFILIATIONS AND ADDITIONAL EXPERIENCE 
	  
	  
Intern	  Liaison	  Training	  Committee,	  VA	  Puget	  Sound	  American	  Lake,	  2017-­‐Present	  
	  
Reviewer	   PLOSOne	  
	   	   APA	  Graduate	  Students	  Science	  Committee	  for	  Basic	  Research	  Science	  Grants,	  
2013-­‐2014	  
	   	   	  
Student	  Rep.	   Clinical	  Training	  Committee,	  University	  of	  Wisconsin—Milwaukee,	  2013-­‐2015	  
	  
AFNI	   	   Week-­‐long	  special	  training	  in	  Analysis	  of	  Functional	  Images	  (AFNI)	  at	  the	  National	  	  
Bootcamp	  	   Institutes	  of	  Health,	  2013	  
	  
Professional	   Member	  of	  Associate	  of	  Graduate	  Students	  in	  Neuropsychology,	  UWM,	  2014-­‐
2017	  
Affiliations	   Student	  Member,	  Society	  for	  Neuroscience,	  2015-­‐2016	  
	   	   Student	  Member,	  Research	  Society	  on	  Alcoholism,	  2015-­‐2016	  
Student	  Affiliate	  of	  APA,	  2013-­‐2015	  
	   	   Student	  Affiliate	  of	  APA	  Division	  40	  (Clinical	  Neuropsychology),	  2013-­‐2015	  
	  
